G-rich polynucleotides for the treatment of huntington's...

C - Chemistry – Metallurgy – 07 – H

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07H 21/04 (2006.01)

Patent

CA 2625035

The present invention relates to oligonucleotide compositions and therapeutic uses thereof to modify protein-protein interactions. In particular, the invention relates to the use of a guanidine-rich oligonucleotides to disrupt disease-causing protein aggregates, for example, Huntington's Disease (HD) protein aggregates.

La présente invention porte sur des compositions oligonucléotidiques et sur leurs utilisations thérapeutiques en vue de modifier les interactions protéine-protéine. L'invention porte, en particulier, sur l'utilisation d'un oligonucléotide riche en guanidine en vue de détruire des agrégats de protéine provoquant une maladie, par exemple, des agrégats de protéine provoquant la maladie de Huntington.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

G-rich polynucleotides for the treatment of huntington's... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with G-rich polynucleotides for the treatment of huntington's..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and G-rich polynucleotides for the treatment of huntington's... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1345381

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.